(KAIT/NBC) - A doctor in Texas said the latest guidelines for genetic testing of breast cancer have limited the number of women who get tested.
According to a report from NBC, Dr. Peter Beitsch attended the biggest breast cancer symposium in the United States recently.
Findings from his study found that genetic testing guidelines meant to save lives may be out of date.
He said they tested 500 women who met the guidelines and 500 women who did not meet the guidelines.
Results showed both groups had exactly the same percentage of pathogenic variants in their genes, which are genetic markers that could show a person is more likely to develop a certain type of cancer.
“Genetic testing is critically important for breast cancer patients, maybe for all cancer patients, because it can affect their treatment right off the bat,” Dr. Bietsch said.
Current guidelines for who qualifies for genetic testing are decades old.
Beitsch believes all cancer patients should receive the genetic testing.
Testing use to cost $5,000 but now prices are as low as $250.
The National Comprehensive Cancer Network said their guidelines are up-to-date.